Aug 08, 2026
AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal
AbCellera (ABCL) stock rose 6% after Q2 earnings and announcement of Phase 2 data for non-hormonal menopause treatment ABCL635 coming August 10, 2026.
The post AbCellera (ABCL) Stock Surges 6% on Menopause Treatment Phase 2 Data Reveal appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 hours ago
Why Palo Alto Networks (PANW) Stock Plunged 10% Despite Strong Earnings
- 2 hours ago
Broadcom (AVGO) Stock Drops 3% Despite Strong Earnings: Should Investors Buy the...
- 2 hours ago
Five Key Stocks on Investors’ Radars This Shortened Trading Week
- 2 hours ago
Markets Brace for CPI Data, Oracle (ORCL) Earnings, and Soaring Diesel Costs Thi...
- 2 hours ago
Arista Networks (ANET) Stock Surges 37% Ahead of S&P 100 Entry